These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27304761)

  • 1. Clozapine-induced esophagitis at therapeutic dose: a case report.
    Gonçalves B; Castro J; Zanini MA; Bittencourt L; Gadelha A; Cunha GR; Coelho FM; Tufik S; Bressan RA; Brietzke E
    Braz J Psychiatry; 2016; 38(2):176-177. PubMed ID: 27304761
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine-associated asterixis: case report.
    Kwak YT; Yang Y; Koo MS
    J Clin Psychopharmacol; 2014 Feb; 34(1):165-7. PubMed ID: 24158019
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of clozapine with nonresponsive patients.
    Markowitz JS; Jackson CW
    Psychiatr Serv; 1996 Dec; 47(12):1392. PubMed ID: 9117483
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report.
    De Berardis D; Campanella D; Serroni N; Rapini G; Olivieri L; Fornaro M; Valchera A; Iasevoli F; Napoletano C; Martinotti G; Giannantonio MD
    J Clin Psychopharmacol; 2014 Oct; 34(5):649-51. PubMed ID: 25006818
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine-induced tardive dyskinesia and hypothyroidism.
    Mendhekar DN; Duggal HS
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):245-6. PubMed ID: 16720805
    [No Abstract]   [Full Text] [Related]  

  • 6. Clozapine rechallenge in a patient with clozapine-induced hepatitis.
    Takács A; Sollychin M; Thomas N; Connally F; Pantelis C
    Australas Psychiatry; 2019 Oct; 27(5):535. PubMed ID: 31545088
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose clozapine and diabetic ketoacidosis.
    Lafayette JM; Pirl WF; Henderson DC
    Psychosomatics; 2003; 44(3):249-52. PubMed ID: 12724507
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful management of clozapine adverse effects with extended (alternate day) antipsychotic dosing in a patient with schizophrenia.
    Kumar V; Sharma L; Madival S; Venkatasubramanian G
    J Psychiatry Neurosci; 2016 Jan; 41(1):E1-2. PubMed ID: 26674512
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study.
    Silver H; Kushnir M; Kaplan A
    Biol Psychiatry; 1996 Oct; 40(7):671-4. PubMed ID: 8886304
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

  • 12. NMS after clozapine initiation.
    Skarpathiotakis M; Westreich N
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-induced acute dystonia in a schizophrenic patient treated with sulpiride and clozapine.
    Chen WH; Huang WL; Hsieh MH
    Psychiatry Clin Neurosci; 2016 Aug; 70(8):362-3. PubMed ID: 27193328
    [No Abstract]   [Full Text] [Related]  

  • 15. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis: A Case Report.
    Danilewitz M; Rafizadeh R; Bousman CA
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):218-220. PubMed ID: 33528148
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible Clozapine Overdose-Associated Thromboembolic Event.
    Sackey B; Miller LJ; Davis MC
    J Clin Psychopharmacol; 2017 Jun; 37(3):364-366. PubMed ID: 28350573
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing clozapine discontinuation - acute and chronic maintenance strategies.
    Shields MK; Bastiampillai T; Mohan T
    Aust N Z J Psychiatry; 2012 Nov; 46(11):1104-5. PubMed ID: 23104931
    [No Abstract]   [Full Text] [Related]  

  • 19. Rechallenge Following Clozapine-Associated Eosinophilia: A Case Report and Literature Review.
    Lally J; OʼConnor N; Fullam S; Corcoran N; OʼReilly A; Jordan J; Guerandel A
    J Clin Psychopharmacol; 2019; 39(5):504-506. PubMed ID: 31335444
    [No Abstract]   [Full Text] [Related]  

  • 20. A Case Report of Clozapine-Associated Stuttering and Amisulpride-Associated Stuttering and Seizure in an Adult on Concurrent Fluoxetine Therapy.
    Mathur R; Singh J; Sood M
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):330-332. PubMed ID: 33675589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.